XM does not provide services to residents of the United States of America.
A
A

Amplifon

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Amplifon Signs Two New Substainability-Linked Credit Facilities For EUR 250 Mln

BRIEF-Amplifon Signs Two New Substainability-Linked Credit Facilities For EUR 250 Mln Oct 15 (Reuters) - Amplifon SpA AMPF.MI : TWO NEW SUBSTAINABILITY-LINKED CREDIT FACILITIES SIGNED FOR EUR 250 MILLION CREDIT FACILITIES COVER TIME FRAME OF 5 YEARS REMAINING EUR 50 MILLION CREDIT FACILITY, SIGNED WITH CREDIT AGRICOLE, WILL FINANCE ROLL-OUT OF NEW
A

JPM raises Amplifon's PT in Q3 preview, shares rise

BUZZ-JPM raises Amplifon's PT in Q3 preview, shares rise ** Shares in Italy's Amplifon AMPF.MI rise 4% after J.P.Morgan raises its PT to 33.7 euros from 31.7 euros in a Q3 preview, bringing attention back to the hearing aid company trading at its lowest levels since October 2023 ** Amplifon will report Q3 results on Oct. 30 ** JPM says the increase
A

Borregaard ASA, Evotec SE, PVA TePla AG

EUROPE RESEARCH ROUNDUP-Borregaard ASA, Evotec SE, PVA TePla AG Oct 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Borregaard ASA, Evotec SE and PVA TePla AG, on Monday. HIGHLIGHTS * Borregaard ASA BRGB.OL : Berenberg raises to buy from hold * Evotec SE EVTG.DE : Jefferies cuts to hold from buy * Experian EXPN.L : Deutsche Bank raises to buy from hold * Intertek Group ITRK.L : Deutsche Bank raises to hold from sell * PVA TePla A
D
E
S
U
A
B

Italy - Factors to watch on September 23

Italy - Factors to watch on September 23 The following factors could affect Italian markets on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Companies such as banks, insurers and energy groups that made extra profits over the past 12-24 months could be subject to a levy of 1% to 2% to help strained public finances, Corriere della Sera report
C
F
U
A
B
J
T
I
U

Sonova drops as Barclays downgrades, saying recent launches priced in

BUZZ-Sonova drops as Barclays downgrades, saying recent launches priced in ** Barclays cuts Sonova SOON.S to "equal-weight" from "overweight", saying the Swiss hearing aid group's most recent launches have already been priced in ** Shares in Sonova are down 1.6% ** Barclays says the company's FY guidance is "achievable", but points to limited catal
S
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.